June 2013
Volume 54, Issue 15
Free
ARVO Annual Meeting Abstract  |   June 2013
EXPERIENCE IN THE USE OF THE EXPRESS DEVICE WITHOUT MYTOMICIN C IN PATIENTS WITH PRIMARY OPEN ANGLE GLAUCOMA
Author Affiliations & Notes
  • Cristina Isida Llerandi
    Glaucoma, Asociación para Evitar la Ceguera en México, Coyoacan, Mexico
  • Hector Bello Lopez Portillo
    Glaucoma, Asociación para Evitar la Ceguera en México, Coyoacan, Mexico
  • Rafael Castañeda Diez
    Glaucoma, Asociación para Evitar la Ceguera en México, Coyoacan, Mexico
  • Magdalena García-Huerta
    Glaucoma, Asociación para Evitar la Ceguera en México, Coyoacan, Mexico
  • Felix Gil Carrasco
    Glaucoma, Asociación para Evitar la Ceguera en México, Coyoacan, Mexico
  • Jesus Jimenez-Roman
    Glaucoma, Asociación para Evitar la Ceguera en México, Coyoacan, Mexico
  • Mauricio Turati-Acosta
    Glaucoma, Asociación para Evitar la Ceguera en México, Coyoacan, Mexico
  • LUIS ZARATE
    Glaucoma, Asociación para Evitar la Ceguera en México, Coyoacan, Mexico
  • Footnotes
    Commercial Relationships Cristina Isida Llerandi, None; Hector Bello Lopez Portillo, None; Rafael Castañeda Diez, None; Magdalena García-Huerta, None; Felix Gil Carrasco, None; Jesus Jimenez-Roman, None; Mauricio Turati-Acosta, None; LUIS ZARATE, None
  • Footnotes
    Support None
Investigative Ophthalmology & Visual Science June 2013, Vol.54, 4781. doi:https://doi.org/
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Cristina Isida Llerandi, Hector Bello Lopez Portillo, Rafael Castañeda Diez, Magdalena García-Huerta, Felix Gil Carrasco, Jesus Jimenez-Roman, Mauricio Turati-Acosta, LUIS ZARATE; EXPERIENCE IN THE USE OF THE EXPRESS DEVICE WITHOUT MYTOMICIN C IN PATIENTS WITH PRIMARY OPEN ANGLE GLAUCOMA. Invest. Ophthalmol. Vis. Sci. 2013;54(15):4781. doi: https://doi.org/.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: To evaluate the efficacy in the control of the intraocular pressure (IOP) with the Express device without the use of Mytomicin C in patients with Primary Open Angle Glaucoma (POAG).

Methods: Prospective, cross sectional and experimental study. 23 eyes of 22 patients with diagnosis of POAG were included. The diagnosis of POAG was made by means of complete ophthalmological examination which included slit lamp examination, IOP meassurement by Goldmann Tonometry, 24-2 Sita standard Visual fields, and optical coherente tomography of the optic nerve and nerve fiber layer analysis. Device implantation was performed by conventional trabeculectomy technique with no use of Mytomicin C. Posterior to the surgery all patients were treated with topical steroids and antibiotic. The IOP was meassured the first and third day post surgery and then every week on first month and then monthly until sixth month. Bleb caractheristics and complications were also evaluated as well as complementary procedures needed.

Results: 23 eyes (22 patients) 4 male and 18 female. Mean age was 66 years. Mean basal tonometry was 17.21 mmHg and mean final IOP 13.82 mmHg. Postsurgical complications included Seidel in seven patients (30.43%) , flat anterior chamber and choroidal detachment was found in two patients (8.69%). One patient had surgical failure who required maximal topical medication (4.34%). Ten patients (43.47%) required needling with 5 fluorouracil aplication. We found conjunctival retraction in one patient (4.34)%) that did not required and additional procedure.

Conclusions: The Express device is usefull in the surgical management in patients with POAG because low complications incidence was obtained as well as good IOP control. Larger population of patients should be evaluated to obtain more concluding results.

Keywords: 568 intraocular pressure • 633 outflow: trabecular meshwork  
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×